Enhanced Multimodal Chromatography Method for HIV-1 Envelope Glycoprotein Purification

An improved multimodal chromatography method for purifying HIV-1 envelope glycoprotein, enabling higher yields, improved purity, and enhanced process efficiency through real-time monitoring and optimized purification conditions.

The original patent (Multimodal chromatography method for the purification of HIV-1 envelope glycoprotein) has limitations in terms of yield, purity, and process efficiency. The new inventive concept addresses these limitations by introducing real-time monitoring, optimized purification conditions, and a combination of anion exchange and hydrophobic interaction chromatography resins.

The enhanced multimodal chromatography method comprises a multimodal chromatography column and a control module for optimizing purification conditions based on real-time monitoring of protein elution profiles. The method involves capturing the HIV-1 envelope glycoprotein on a multimodal resin, washing the resin with a buffer solution having a controlled ionic strength, and eluting the protein with a buffer solution having a controlled pH and ionic strength. The combination of anion exchange and hydrophobic interaction chromatography resins enables higher yields and improved purity. The control module optimizes the buffer composition, pH, and ionic strength to minimize protein aggregation and maximize yield.

The new inventive concept introduces the use of real-time monitoring, optimized purification conditions, and a combination of anion exchange and hydrophobic interaction chromatography resins, which are not present in the original patent. These novel features enable higher yields, improved purity, and enhanced process efficiency.

Alternative embodiments of the inventive concept include using different types of multimodal resins, varying the buffer composition and pH, and incorporating additional purification steps. Variations of the control module could include different algorithms for optimizing purification conditions and integrating with different types of chromatography systems.

The enhanced multimodal chromatography method has significant commercial potential in the biotechnology and pharmaceutical industries, particularly in the development of HIV vaccines and therapeutics. The improved yield, purity, and process efficiency of the inventive concept make it an attractive solution for large-scale production of HIV-1 envelope glycoprotein.